. Cellular fold recovery after 7 days culture. 
Figure S5. IL-10 production by Th1, Th2 and Th17 cells is inhibited by the MEK inhibitor, but not by a p38 inhibitor, nor a GSK3β inhibitor.
CD4 + T cells were isolated and cultured for 7 days in the presence of plate bound anti-CD3, anti-CD28 and IL-12 (3ng/ml), Th1; IL-4 (10ng/ml) plus anti-IFN-γ (10μg/ml), Th2; or IL-6 (50ng/ml), TGF-β (1ng/ml) and IL-1 (10ng/ml), Th17; all in the absence -harvest cells -restimulate with 2 µg/ml of plate-bound αCD3 and 2 µg/ml of soluble αCD28 for 4h, the last 2h in the presence of brefeldin A; cytokine production analysed by ICS -restimulate with 2 µg/ml of plate-bound αCD3 and 2 µg/ml of soluble αCD28 for 3h (RNA) or 24h (ELISA) -restimulate with 2 µg/ml of plate-bound αCD3 and 2 µg/ml of soluble αCD28 for 4h, the last 2h in the presence of brefeldin A; cytokine production analysed by ICS RECULTURE WITH SORT PURIFIED sp DC FOR A SECOND WEEK as above but also with IL-2 Low antigen dose-driven Th2: 0.05 μM OVA; no IL-4 * IL-4-driven Th2: IL-4 at 10 ng/ml; αIL-12 at 10 μg/ml; 1 μM OVA Experimental flowchart used for Figures 5C and 5D 
Th17
Th1 and Th2 * Th1: IL-12 at 3 ng/ml; * Th2: IL-4 at 10 ng/ml; * Th17: IL-6 at 50 ng/ml; TGF-β at 1 ng/ml; IL-1 at 10 ng/ml Supplementary Figures 6 and 7: Schematic representation of the experimental design used in this work.
